SCHEMBL30245107

SCHEMBL30245107

COc1cccc(CN(Cc2ccc(N3CCOCC3)cc2)c2ccc(COCCOCCN3CCOCC3)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ DRD2 P14416 2/20 0.43
▸ DRD4 P21917 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ROCK2 O75116 2/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ ABCB1 P08183 4/20 0.41
▸ LTA4H P09960 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.39
▸ F2R P25116 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245058 0.98 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL30245609 0.96 ALDH1A1 (0.44) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL30245483 0.96 DRD2 (0.44) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL25298289 0.96 DRD2 (0.44) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL25298985 0.96 ALDH1A1 (0.44) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL30245076 0.96 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL25261051 0.95 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL25258582 0.95 DRD2 (0.46) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL30245231 0.95 DRD2 (0.46) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2
SCHEMBL30245846 0.95 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2NPSR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP claimed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO claimed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO claimed
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP disclosed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO disclosed
Send feedback